Unrevealing of dysregulated hub genes linked with immune system and inflammatory signaling pathways in the pathogenesis of irritable bowel syndrome by system biology approaches

[1]  Huiping Liang,et al.  HLA-A and HLA-B genes are involved in the pathogenesis of IBS , 2023, Medicine.

[2]  E. Mayer,et al.  The neurobiology of irritable bowel syndrome , 2023, Molecular Psychiatry.

[3]  Binbin Tang,et al.  Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome , 2023, Heliyon.

[4]  Y. Guan,et al.  CD4+ T cell activation and inflammation in NASH-related fibrosis , 2022, Frontiers in Immunology.

[5]  Fengyun Wang,et al.  Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study , 2022, Frontiers in Medicine.

[6]  Yueming Shen,et al.  Endoplasmic reticulum stress contributed to inflammatory bowel disease by activating p38 MAPK pathway , 2022, European journal of histochemistry : EJH.

[7]  G. Boeckxstaens,et al.  Publisher Correction: Immune activation in irritable bowel syndrome: what is the evidence? , 2022, Nature Reviews Immunology.

[8]  Minjian Chen,et al.  Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome , 2022, Frontiers in Endocrinology.

[9]  L. Mao,et al.  Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines , 2021, European Journal of Nutrition.

[10]  C. Ferrone,et al.  Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors: A Review. , 2021, JAMA oncology.

[11]  Piplu Bhuiyan,et al.  Bidirectional communication between mast cells and the gut-brain axis in neurodegenerative diseases: Avenues for therapeutic intervention , 2021, Brain Research Bulletin.

[12]  Piplu Bhuiyan,et al.  Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases , 2021, Neural regeneration research.

[13]  Tatsuo Kawai,et al.  Adipose Tissue Inflammation and Metabolic Dysfunction in Obesity. , 2020, American journal of physiology. Cell physiology.

[14]  Dapeng Chen,et al.  Advancements of compounds targeting Wnt and Notch signalling pathways in the treatment of inflammatory bowel disease and colon cancer , 2020, Journal of drug targeting.

[15]  N. H. Zaki,et al.  Susceptibility role of soluble HLA-G and HLA-G 14-bp insertion/deletion polymorphism in inflammatory bowel disease , 2020, Egyptian Journal of Medical Human Genetics.

[16]  P. Bercik.  The Brain-Gut-Microbiome Axis and Irritable Bowel Syndrome. , 2020, Gastroenterology & hepatology.

[17]  P. Whorwell,et al.  Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. , 2020, Gastroenterology.

[18]  M. Gazouli,et al.  Inflammatory bowel disease pathobiology: the role of the interferon signature , 2020, Annals of gastroenterology.

[19]  Runan Yao,et al.  ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..

[20]  Xinlin Chen,et al.  Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways , 2019, BMC Complementary and Alternative Medicine.

[21]  T. Winkler,et al.  IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption. , 2019, The Journal of clinical investigation.

[22]  S. Ennis,et al.  Review article: the genetics of the human leucocyte antigen region in inflammatory bowel disease , 2019, Alimentary pharmacology & therapeutics.

[23]  W. Wong,et al.  The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy , 2019, Front. Microbiol..

[24]  F. Powrie,et al.  Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease. , 2019, Immunity.

[25]  Mario Medvedovic,et al.  GREIN: An Interactive Web Platform for Re-analyzing GEO RNA-seq Data , 2018, Scientific Reports.

[26]  Denis Torre,et al.  eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks , 2018, Nucleic Acids Res..

[27]  J. Prinz.  Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis , 2018, Front. Immunol..

[28]  Yan Zheng,et al.  Modulation of inflammation by toll-like receptor 4/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome , 2017, Oncotarget.

[29]  G. Núñez,et al.  Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease , 2017, Immunological reviews.

[30]  P. Tso,et al.  Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease , 2017, Front. Immunol..

[31]  P. He,et al.  SP and KLF Transcription Factors in Digestive Physiology and Diseases. , 2017, Gastroenterology.

[32]  Jixin Zhong,et al.  Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation , 2017, Journal of diabetes research.

[33]  H. Pommergaard,et al.  Irritable bowel syndrome, the microbiota and the gut-brain axis , 2016, Gut microbes.

[34]  E. Quigley,et al.  Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators , 2016, Journal of digestive diseases.

[35]  X. Hou,et al.  Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside , 2016, Journal of neurogastroenterology and motility.

[36]  M. Fiorentino,et al.  Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[37]  J. Ochoa-Repáraz,et al.  The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? , 2016, Current Obesity Reports.

[38]  T. Dinan,et al.  Stress and the Microbiota–Gut–Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome , 2016, CNS neuroscience & therapeutics.

[39]  Ching-Seng Ang,et al.  FunRich: An open access standalone functional enrichment and interaction network analysis tool , 2015, Proteomics.

[40]  Yanfen Xing,et al.  Expression of Wnt and Notch signaling pathways in inflammatory bowel disease treated with mesenchymal stem cell transplantation: evaluation in a rat model , 2015, Stem Cell Research & Therapy.

[41]  M. Carabotti,et al.  The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems , 2015, Annals of gastroenterology.

[42]  Satish S. C. Rao,et al.  Brain and Gut Interactions in Irritable Bowel Syndrome: New Paradigms and New Understandings , 2014, Current Gastroenterology Reports.

[43]  Li-hui Wang,et al.  Low SP1 Expression Differentially Affects Intestinal-Type Compared with Diffuse-Type Gastric Adenocarcinoma , 2013, PloS one.

[44]  A. Zinsmeister,et al.  Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[45]  Stephen T. C. Wong,et al.  A gene signature based method for identifying subtypes and subtype-specific drivers in cancer with an application to medulloblastoma , 2012, 2012 IEEE 2nd International Conference on Computational Advances in Bio and medical Sciences (ICCABS).

[46]  G. Barbara,et al.  The Immune System in Irritable Bowel Syndrome , 2011, Journal of neurogastroenterology and motility.

[47]  Clara Abraham,et al.  Interactions between the host innate immune system and microbes in inflammatory bowel disease. , 2011, Gastroenterology.

[48]  T. Dinan,et al.  Irritable bowel syndrome: towards biomarker identification. , 2009, Trends in molecular medicine.

[49]  M. Spehlmann,et al.  Nuclear factor-kappa B in intestinal protection and destruction , 2009, Current opinion in gastroenterology.

[50]  T. Ahmad,et al.  Genetics of inflammatory bowel disease: the role of the HLA complex. , 2006, World journal of gastroenterology.

[51]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[52]  Wangxue Chen,et al.  Activation of the mucosal immune system in irritable bowel syndrome. , 2002, Gastroenterology.

[53]  H. Kitano.  Systems Biology: A Brief Overview , 2002, Science.

[54]  G. Ni,et al.  Relationship between HLA-DRB1 and DQ alleles and the genetic susceptibility to type 1 diabetes. , 2001, Chinese medical journal.

[55]  J. Yewdell,et al.  The export of major histocompatibility complex class I molecules from the endoplasmic reticulum of rat brown adipose cells is acutely stimulated by insulin. , 2001, Molecular biology of the cell.

[56]  R. Spiller,et al.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acuteCampylobacter enteritis and in post-dysenteric irritable bowel syndrome , 2000, Gut.

[57]  G. Sturniolo,et al.  [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.